The Enterprise Value as of December 2025 (TTM) for Zelira Therapeutics Limited (ZLDAF) is 6.18M

According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 6.18M. This represents a change of -39.96% compared to the average of 10.29M of the last 4 quarters.

Zelira Therapeutics Limited (ZLDAF) Historical Enterprise Value (quarterly & annually)

How has ZLDAF Enterprise Value performed in the past?

The mean historical Enterprise Value of Zelira Therapeutics Limited over the last ten years is 24.45M. The current 6.18M Enterprise Value has changed 2.43% with respect to the historical average. Over the past ten years (40 quarters), ZLDAF's Enterprise Value was at its highest in in the December 2020 quarter at 89.61M. The Enterprise Value was at its lowest in in the June 2012 quarter at -185840.06.

Zelira Therapeutics Limited (ZLDAF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zelira Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zelira Therapeutics Limited (ZLDAF) Average Enterprise Value

How has ZLDAF Enterprise Value performed in the past?

The current Enterprise Value of Zelira Therapeutics Limited (ZLDAF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Zelira Therapeutics Limited (ZLDAF) Enterprise Value vs. Peers

How is ZLDAF’s Enterprise Value compared to its peers?

Zelira Therapeutics Limited’s Enterprise Value is greater than ProtoKinetix, Incorporated (1.76M), less than Acrux Limited (9.34M), less than AXIM Biotechnologies, Inc. (14.70M), greater than HAVN Life Sciences Inc. (487.77K), greater than Algernon Pharmaceuticals Inc. (2.65M), greater than Sigyn Therapeutics, Inc. (5.94M), greater than ReNeuron Group plc (-5684907.22), greater than RepliCel Life Sciences Inc. (2.20M), less than Appili Therapeutics Inc. (14.26M), less than Radient Technologies Inc. (0),

Build a custom stock screener for Zelira Therapeutics Limited (ZLDAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zelira Therapeutics Limited (ZLDAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.